Some patients may be better served by another prescription medication, nutrition changes, behavioral support, or a different medical approach
The profile of 17-estradiol displays maximal levels around the mid-to-late 20s in women [10] (Fig
3,4 Patients with NASH have a higher risk of progression to advanced stages of fibrosis, cirrhosis, hepatocellular carcinoma and other end-stage liver disease complications
On the other hand, RWE lacks the ability to establish causality by minimising confounding effects which is a key strength of randomised clinical trials (RCTs)
Gastrointestinal adverse effects, including eructation, are well-documented with GLP-1 receptor agonist therapies in the MHRA/EMC SmPC for Mounjaro
Malhotra A (2024) Phase 3 trial of semaglutide in obstructive sleep apnea